PTSM: Pharmaceutical Technology Sourcing and Management
The investment doubles the company’s capacity to meet increasing demand for its biologics contract testing and biosimilar characterization services.
BioOutsource, part of Sartorius Stedim Biotech Group, has opened a new facility in Glasgow. The investment follows the increasing demand for the company’s biologics contract testing and biosimilar characterization services. The new facility doubles BioOutsource’s capacity for future growth and will create approximately 50 new jobs for scientific and technical professionals in the next six months, according to the company.
Source:
over 11 years ago
CDMOs Move Slowly with Expansion Plansover 11 years ago
Accelerating Continuous API Synthesisover 11 years ago
Silicone Rubber Pieces Spur Recall of Teva Productover 11 years ago
Baxter Recalls IV Solution for Container and Particulate Issuesover 11 years ago
Indian API Manufacturer Cited for Recordkeeping Failuresover 11 years ago
Xcelience Makes Investment in Powdersizeover 11 years ago
FDA Issues Quality Metrics Draft Guidance Document for Commentover 11 years ago
EMA Issues Guideline on Fast Tracking Drugs for Unmet Needsover 11 years ago
SafeBridge Updates Potent API and Drug Manufacturer Status
